🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT07783919
Starting soon Not applicable

Single-Shot Versus Focal Dual-Energy Pulsed Field-Based Ablation for Atrial Fibrillation

NCT07783919 · tracked via the Priya Life Science Germany tracker
Sponsor
Marien Hospital Herne
Phase
Not applicable
Started
2026-09-01
Last updated
2026-08-25

Condition(s) studied

Atrial Fibrillation (AF)

Investigational drug(s) / intervention(s)

Catheter Ablation for Atrial Fibrillation

Catheter Ablation for Atrial Fibrillation: PFA-based Catheter Ablation for Atrial Fibrillation (PFA single shot vs. focal dual-eregy)

Study summary

Comparison of single-shot PFA systems with focal dual-energy (PFA/RF) in patients at high risk of atrial fibrillation recurrence.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * First-time pulmonary vein isolation * Symptomatic atrial fibrillation: * Paroxysmal atrial fibrillation (≥ 2 episodes in the last 6 months) and one of the following: CHA2DS2VA score ≥ 2, ≥ 1 cardioversion in the last 6 months or Left atrial (LA) diameter ≥ 45 mm o or persistent atrial fibrillation (≥ 1 episode in the last 6 months) Exclusion Criteria: * Atrial fibrillation due to reversible or non-cardiac causes * Severe mitral or tricuspid valve regurgitation requiring therapy * Previous left atrial endocardial or epicardial ablation * Pregnancy or breastfeeding * Lack of opportunity for reliable study participation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Marien Hospital Herne Herne North Rhine-Westphalia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07783919 on ClinicalTrials.gov ↗ ← All trials in Germany